Search research articles
Contact Us
Filters
Showing results (1-10 of 100) with videos related to
Page
of 10
Sort By:
Cancer Journal (Sudbury, Mass.)
|
January 24, 2017
New Combination Strategies Using Programmed Cell Death 1/Programmed Cell Death Ligand 1 Checkpoint Inhibitors as a Backbone
Siwen Hu-Lieskovan, Antoni Ribas
The Journal of Experimental Medicine
|
December 2, 2016
What does PD-L1 positive or negative mean?
Antoni Ribas, Siwen Hu-Lieskovan
Drugs
|
February 26, 2020
Mechanisms of Resistance to PD-1 Checkpoint Blockade
Justin C Moser, Siwen Hu-Lieskovan
Seminars in Immunology
|
February 11, 2016
Combining targeted therapy with immunotherapy. Can 1+1 equal more than 2?
Lidia Robert, Antoni Ribas, Siwen Hu-Lieskovan
Cancer Journal (Sudbury, Mass.)
|
January 24, 2018
Mechanisms of Resistance to PD-1 and PD-L1 Blockade
Theodore S Nowicki, Siwen Hu-Lieskovan, Antoni Ribas
Cancer Cell
|
June 10, 2015
Excluding T Cells: Is β-Catenin the Full Story?
Siwen Hu-Lieskovan, Blanca Homet Moreno, Antoni Ribas
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
July 17, 2023
Immune Resistance Mechanisms and the Road to Personalized Immunotherapy
Miles Piper, Harriet Kluger, Eytan Ruppin, et al.
Melanoma Research
|
December 20, 2024
Pembrolizumab-induced acquired lipodystrophy: a case report and review of the literature
John Marsiglio, Jordan McPherson, Matthew Wahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2014
Combining targeted therapy with immunotherapy in BRAF-mutant melanoma: promise and challenges
Siwen Hu-Lieskovan, Lidia Robert, Blanca Homet Moreno, et al.
The Science of the Total Environment
|
July 11, 2024
Ecological restoration enhanced the stability of epiphytic microbial food webs of submerged macrophytes: Insights from predation characteristics of epiphytic predators
Xiaojian Sun, Siwen Hu, Rujia He, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 100) with videos related to
Sort By:
Page
of 10
Cancer Journal (Sudbury, Mass.)
|
January 24, 2017
New Combination Strategies Using Programmed Cell Death 1/Programmed Cell Death Ligand 1 Checkpoint Inhibitors as a Backbone
Siwen Hu-Lieskovan, Antoni Ribas
The Journal of Experimental Medicine
|
December 2, 2016
What does PD-L1 positive or negative mean?
Antoni Ribas, Siwen Hu-Lieskovan
Drugs
|
February 26, 2020
Mechanisms of Resistance to PD-1 Checkpoint Blockade
Justin C Moser, Siwen Hu-Lieskovan
Seminars in Immunology
|
February 11, 2016
Combining targeted therapy with immunotherapy. Can 1+1 equal more than 2?
Lidia Robert, Antoni Ribas, Siwen Hu-Lieskovan
Cancer Journal (Sudbury, Mass.)
|
January 24, 2018
Mechanisms of Resistance to PD-1 and PD-L1 Blockade
Theodore S Nowicki, Siwen Hu-Lieskovan, Antoni Ribas
Cancer Cell
|
June 10, 2015
Excluding T Cells: Is β-Catenin the Full Story?
Siwen Hu-Lieskovan, Blanca Homet Moreno, Antoni Ribas
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
July 17, 2023
Immune Resistance Mechanisms and the Road to Personalized Immunotherapy
Miles Piper, Harriet Kluger, Eytan Ruppin, et al.
Melanoma Research
|
December 20, 2024
Pembrolizumab-induced acquired lipodystrophy: a case report and review of the literature
John Marsiglio, Jordan McPherson, Matthew Wahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2014
Combining targeted therapy with immunotherapy in BRAF-mutant melanoma: promise and challenges
Siwen Hu-Lieskovan, Lidia Robert, Blanca Homet Moreno, et al.
The Science of the Total Environment
|
July 11, 2024
Ecological restoration enhanced the stability of epiphytic microbial food webs of submerged macrophytes: Insights from predation characteristics of epiphytic predators
Xiaojian Sun, Siwen Hu, Rujia He, et al.
Page
of 10